Pangaea Oncology S.A. (PANG) — Strategic Asset Allocation Index
Pangaea Oncology S.A. (PANG) has a Strategic Asset Allocation Index of 1.5% as of December 2022. Strategic assets (PP&E of €352.52K plus long-term investments of €-) total €352.52K, measured against net assets of €23.08 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See PANG net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Pangaea Oncology S.A. Strategic Asset Allocation Index (2020–2022)
This chart shows how Pangaea Oncology S.A.'s Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of December 2022, the index stands at 1.5%, representing strategic assets of €352.52K against net assets of €23.08 Million EUR. For live market cap and overall valuation, see how much is Pangaea Oncology S.A. worth.
Annual Strategic Asset Allocation Index for Pangaea Oncology S.A. (2020–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Pangaea Oncology S.A. from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Pangaea Oncology S.A. (PANG) net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 1.5% | €352.52K | €352.52K | €- | €23.08 Million | ▼ -1.5 pp |
| 2021 | 3.0% | €429.41K | €429.41K | €- | €14.09 Million | ▼ -3.4 pp |
| 2020 | 6.5% | €553.07K | €553.07K | €- | €8.57 Million | — |